COMBINATION POTENTIATOR (‘CO-POTENTIATOR’) THERAPY FOR CF CAUSED BY CFTR MUTANTS, INCLUDING N1303K, THAT ARE POORLY RESPONSIVE TO SINGLE POTENTIATORS

類似資料

• Nanomolar-potency ‘co-potentiator’ therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants
  著者:: Phuan, Puay-Wah, 等
  出版事項: (2019)
• Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product
  著者:: Haggie, Peter M., 等
  出版事項: (2017)
• Fluorinated ΔF508-CFTR Correctors and Potentiators for PET Imaging
  著者:: Davison, Holly R., 等
  出版事項: (2012)
• Inhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis
  著者:: Haggie, Peter M., 等
  出版事項: (2016)
• Potentiators of Defective ΔF508–CFTR Gating that Do Not Interfere with Corrector Action
  著者:: Phuan, Puay-Wah, 等
  出版事項: (2015)